Obesity Medicine

Latest News

Investigational Probiotic Drug Gains FDA Support for Phase 2 Obesity Trial
Investigational Probiotic Drug Gains FDA Support for Phase 2 Obesity Trial

April 24th 2025

Northstrive Biosciences received positive FDA feedback for its IND application for EL-22, a probiotic-based treatment for obesity.

ACS 2025 Report: Cervical Cancer Screening and HPV Vaccination Lag Despite Smoking Declines /image credit ©Sebastien Garcia/stock.adobe.com
Smoking Rates Hit New Low, But Cervical Cancer Screening Still Lags: 2025 ACS Report

April 24th 2025

Lilly’s Oral GLP-1 Orforglipron Shows Significant A1c and Weight Reductions in Phase 3 Trial / image credit ©MichaelVi/stock.adobe.com
Lilly’s Oral GLP-1 Orforglipron Shows Significant and Competitive A1c and Weight Reductions in Phase 3 Trial

April 17th 2025

 Mediterranean Diet Combined with Physical Activity Mitigate Bone Density Decline in Older, At-Risk Women, New Analysis Finds / image credit  Rovira i Virgili University
Mediterranean Diet Combined with Physical Activity Mitigate Bone Density Decline in Older, At-Risk Women, New Analysis Finds

April 15th 2025

FDA, Novo Nordisk Investigating Counterfeit Semaglutide Injection in US Supply Chain / Image credit: ©Natalia/AdobeStock
FDA, Novo Nordisk Investigating Counterfeit Semaglutide Injection in US Supply Chain

April 14th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.